Get the Stockscreener App
1.63
1.81%
-0.03
Curis Inc stock is traded at $1.63, with a volume of 60,478.
It is down -1.81% in the last 24 hours and down -24.19% over the past month.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
See More
Previous Close:
$1.66
Open:
$1.66
24h Volume:
60,478
Relative Volume:
0.52
Market Cap:
$17.05M
Revenue:
$10.16M
Net Income/Loss:
$-47.57M
P/E Ratio:
-0.1978
EPS:
-8.24
Net Cash Flow:
$-42.73M
1W Performance:
-11.41%
1M Performance:
-24.19%
6M Performance:
-53.69%
1Y Performance:
-67.00%
1-Day Range:
$1.57
$1.675
1-Week Range:
$1.57
$1.8791
52-Week Range:
$1.02
$8.29
Curis Inc Stock (CRIS) Company Profile
Name
Curis Inc
Sector
Industry
Phone
617-503-6500
Address
128 SPRING STREET, LEXINGTON, MA
Compare CRIS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRIS
Curis Inc
|
1.63 | 19.92M | 10.16M | -47.57M | -42.73M | -8.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Curis Inc Stock (CRIS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-19-25 | Resumed | H.C. Wainwright | Buy |
| Nov-17-23 | Initiated | Truist | Buy |
| Apr-04-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-13-21 | Initiated | Raymond James | Outperform |
| Mar-25-21 | Initiated | B. Riley Securities | Buy |
| Jul-29-20 | Initiated | Laidlaw | Buy |
| Jul-17-20 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-24-17 | Initiated | Guggenheim | Buy |
| Mar-02-16 | Initiated | Sun Trust Rbsn Humphrey | Buy |
| Nov-09-15 | Reiterated | ROTH Capital | Buy |
| Aug-11-15 | Initiated | FBR Capital | Outperform |
| Jan-22-15 | Reiterated | Oppenheimer | Outperform |
| Jan-21-15 | Reiterated | ROTH Capital | Buy |
| May-09-14 | Reiterated | Oppenheimer | Outperform |
| Oct-02-13 | Initiated | Robert W. Baird | Outperform |
| Sep-30-13 | Initiated | Chardan Capital Markets | Buy |
| Nov-14-12 | Initiated | Stifel Nicolaus | Hold |
| Jan-31-12 | Reiterated | Brean Murray | Buy |
| Jan-31-12 | Reiterated | Summer Street Research | Buy |
| Dec-09-11 | Initiated | Oppenheimer | Outperform |
| Oct-06-11 | Initiated | Summer Street Research | Buy |
| Sep-22-11 | Initiated | MLV Capital | Buy |
| Mar-21-11 | Reiterated | Brean Murray | Buy |
| Feb-26-10 | Reiterated | Roth Capital | Buy |
| Jan-07-10 | Initiated | Roth Capital | Buy |
View All
Curis Inc Stock (CRIS) Latest News
What institutional investors are buying Curis Inc. stockBreakout Stocks Ideas For 2025 - jammulinksnews.com
What is Curis Inc. company’s growth strategyAI Powered Tracker To Watch Now - jammulinksnews.com
How strong is Curis Inc. company’s balance sheetFree Stock Insights For Every Investor - jammulinksnews.com
Why is Curis Inc. stock attracting strong analyst attentionBeginner Investor Ideas For Smart Trading - jammulinksnews.com
What are Curis Inc. company’s key revenue driversPost Market Planner That Work - jammulinksnews.com
Curis Inc. stock retracement – recovery analysisPattern Breakout Tracker with Screener Tools - Newser
Combining machine learning predictions for Curis Inc.Technical Confirmation System with Signal Alerts - Newser
What is the dividend policy of Curis Inc. stockAI Powered Target Finder For Consistent Profits - jammulinksnews.com
How does Curis Inc. compare to its industry peersFree Stock Tracker With Low Risk - jammulinksnews.com
Wealthquest Corp Takes $1.54 Million Position in Curis, Inc. (NASDAQ:CRIS) - Defense World
Can machine learning forecast Curis Inc. recoveryTechnical Setup and Return Forecast Engine - Newser
Will Curis Inc. stock benefit from interest rate changesStock Trading Session Highlights and Summary - Newser
Curis reports Q1 EPS ($1.25), consensus ($1.26) - TipRanks
Curis to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on August 5, 2025 - BioSpace
Why Curis Inc. stock attracts strong analyst attentionShort Term Trading Opportunity Watch Sees Shift - beatles.ru
Key resistance and support levels for Curis Inc.Consistent Profit Signals with AI Models - Newser
How Curis Inc. stock performs during market volatilityExit Ready Momentum Stock Watchlist Expanded - metal.it
Curis Inc. Stock Recovery Path — Analyst BreakdownRisk Controlled Picks With Real Returns Outlined - metal.it
Curis Sets Q2 Earnings Date: Latest Updates on IRAK4 Inhibitor Development Expected - Stock Titan
Should I hold or sell Curis Inc. stock in 2025Daily Trading Picks Backed By Experts - jammulinksnews.com
How did CRIS's Q4 2024 EPS surprise compare to forecasts? - AInvest
What makes Curis Inc. stock price move sharplyMarket Sentiment Tracker with Smart Alerts - Newser
What are the technical indicators suggesting about Curis Inc.Daily Trading Ideas For Fast Growth - jammulinksnews.com
When is Curis Inc. stock expected to show significant growthUnlock exclusive stock analysis for investors - jammulinksnews.com
Using R and stats models for Curis Inc. forecastingFree Scalable Portfolio Growth Suggestions - Newser
How Curis Inc. stock performs during market volatility Proven Trading System with Consistent Gains - Newser
Is it the right time to buy Curis Inc. stockExceptional market positioning - jammulinksnews.com
What are analysts’ price targets for Curis Inc. in the next 12 monthsInvest confidently with real-time market updates - jammulinksnews.com
Is Curis Inc. a growth stock or a value stockBreakout portfolio performance - jammulinksnews.com
What catalysts could drive Curis Inc. stock higher in 2025Build a diversified portfolio for steady profits - jammulinksnews.com
What markets is TNET expanding into Is Curis Inc. stock a good long term investment optionFind the best stocks for sustainable growth - jammulinksnews.com
Is Curis Inc. Stock a Good Fit for Conservative InvestorsStrategic High Profit Opportunities - metal.it
Curis Inc. Stock Analysis and ForecastFree Stock Market Query - PrintWeekIndia
What analysts say about Curis Inc. stockExplosive wealth accumulation - Autocar Professional
What analysts say about Curis Inc. stock outlookHigh-performance investment picks - jammulinksnews.com
Why Curis Inc. stock is on top investor watchlistsFree Stock Market Forecast Reports - jammulinksnews.com
When is the best time to buy Curis Inc. stockSuperior capital gains - jammulinksnews.com
Curis Inc Stock (CRIS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):